Published in J Nephrol on December 22, 2000
Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest (2003) 12.56
Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis. Nat Med (2013) 2.55
Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis. Am J Physiol Cell Physiol (2012) 1.70
A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J Clin Invest (2002) 1.70
Integration of Golgi trafficking and growth factor signaling by the lipid phosphatase SAC1. J Cell Biol (2008) 1.58
The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease. Nat Rev Nephrol (2010) 1.46
Fibronectin matrix turnover occurs through a caveolin-1-dependent process. Mol Biol Cell (2004) 1.40
The role of the p38 MAPK signaling pathway in high glucose-induced epithelial-mesenchymal transition of cultured human renal tubular epithelial cells. PLoS One (2011) 1.20
Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers. Am J Cancer Res (2011) 1.18
The biology and function of fibroblasts in cancer. Nat Rev Cancer (2016) 1.16
Mutations in bone marrow-derived stromal stem cells unmask latent malignancy. Stem Cells Dev (2010) 1.05
tPA protects renal interstitial fibroblasts and myofibroblasts from apoptosis. J Am Soc Nephrol (2008) 1.04
The alpha8 integrin chain affords mechanical stability to the glomerular capillary tuft in hypertensive glomerular disease. Am J Pathol (2002) 0.99
CD248 facilitates tumor growth via its cytoplasmic domain. BMC Cancer (2011) 0.93
Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblasts. Mediators Inflamm (2007) 0.92
tPA activates LDL receptor-related protein 1-mediated mitogenic signaling involving the p90RSK and GSK3beta pathway. Am J Pathol (2010) 0.91
The colon cancer stem cell microenvironment holds keys to future cancer therapy. J Gastrointest Surg (2014) 0.88
Physiology of the Renal Interstitium. Clin J Am Soc Nephrol (2015) 0.84
Renal studies provide an insight into cardiac extracellular matrix remodeling during health and disease. J Mol Cell Cardiol (2009) 0.84
Epithelial-mesenchymal transitions and the intersecting cell fate of fibroblasts and metastatic cancer cells. Trans Am Clin Climatol Assoc (2003) 0.81
An HSV-TK transgenic mouse model to evaluate elimination of fibroblasts for fibrosis therapy. Am J Pathol (2003) 0.81
Lefty-1 alleviates TGF-β1-induced fibroblast-myofibroblast transdifferentiation in NRK-49F cells. Drug Des Devel Ther (2015) 0.78
Fibroblast sources: Where can we get them? Cytotechnology (2014) 0.77
Fibroblasts regulate variable aggressiveness of syndromic keratocystic and non-syndromic odontogenic tumors. J Dent Res (2014) 0.77
β-Thalassemia Intermedia: A Bird's-Eye View. Turk J Haematol (2014) 0.76
Electric Cell-Substrate Impedance Sensing (ECIS) with Microelectrode Arrays for Investigation of Cancer Cell - Fibroblasts Interaction. PLoS One (2016) 0.75
Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Accelerates the Progression of Renal Fibrosis in Lupus Nephritis by Activating SMAD and p38 MAPK in TGF-β1 Signaling Pathway. Mediators Inflamm (2016) 0.75
The third path of tubulointerstitial fibrosis: aberrant endothelial secretome. Kidney Int (2017) 0.75
Gene Expression Contributes to the Recent Evolution of Host Resistance in a Model Host Parasite System. Front Immunol (2017) 0.75
Reduction of background problems in nonradioactive northern and Southern blot analyses enables higher sensitivity than 32P-based hybridizations. Anal Biochem (1993) 2.93
Retracted Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nat Med (2000) 2.64
Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am J Pathol (2001) 2.18
Paraneoplastic hypokalemia in acute myeloid leukemia: a case of renin activity in AML blast cells. Ann Hematol (1996) 2.05
[Long-term analysis of clinical disease activity and chronic organ damage in patients with systemic lupus erythematosus]. Z Rheumatol (2002) 2.04
Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging (2003) 1.89
The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis. Pathol Res Pract (1991) 1.68
Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. J Am Soc Nephrol (2001) 1.67
Renal fibrosis: an update. Curr Opin Nephrol Hypertens (2001) 1.64
Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome. Intensive Care Med (1999) 1.55
Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Kidney Int Suppl (1996) 1.39
Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol (2000) 1.32
Possible mechanisms of renal fibrosis. Contrib Nephrol (1996) 1.28
Identification of a novel cis-acting element for fibroblast-specific transcription of the FSP1 gene. Am J Physiol (1998) 1.22
Role of mast cell tryptase in renal interstitial fibrosis. J Am Soc Nephrol (2001) 1.20
Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. Am J Kidney Dis (1991) 1.19
Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation. Kidney Int (2000) 1.15
The long-term prognosis of the primary glomerulonephritides. A morphological and clinical analysis of 1747 cases. Pathol Res Pract (1992) 1.15
On the pathogenesis of chronic renal failure in primary glomerulopathies: a view from the interstitium. Exp Nephrol (1994) 1.14
Prospective 7 year follow up imaging study comparing radiography, ultrasonography, and magnetic resonance imaging in rheumatoid arthritis finger joints. Ann Rheum Dis (2005) 1.13
Diagnosis and follow up of aortitis in the elderly. Ann Rheum Dis (2004) 1.09
Transdifferentiation: a new angle on renal fibrosis. Exp Nephrol (1997) 1.04
Transdifferentiation comes of age. Nephrol Dial Transplant (2000) 1.04
Biological responses to PDGF-BB versus PDGF-DD in human mesangial cells. Kidney Int (2006) 0.99
First clinical evaluation of sagittal laser optical tomography for detection of synovitis in arthritic finger joints. Ann Rheum Dis (2004) 0.99
Cytokines in human renal interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblasts. Kidney Int (1995) 0.99
The importance of tubulointerstitial damage in progressive renal disease. Nephrol Dial Transplant (2000) 0.99
Cytokines in human renal interstitial fibrosis. II. Intrinsic interleukin (IL)-1 synthesis and IL-1-dependent production of IL-6 and IL-8 by cultured kidney fibroblasts. Kidney Int (1995) 0.98
Increased expression of CD40 ligand (CD154) on CD4+ T cells as a marker of disease activity in rheumatoid arthritis. Ann Rheum Dis (2000) 0.98
The haploinsufficient Col3a1 mouse as a model for vascular Ehlers-Danlos syndrome. Vet Pathol (2010) 0.94
[Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses: clinical experience with 16 patients]. Nervenarzt (2006) 0.94
Pathogenesis of chronic renal failure in primary glomerulopathies. Nephrol Dial Transplant (1994) 0.93
Progressive multifocal leukoencephalopathy in a renal transplant patient diagnosed by JCV-specific DNA amplification and an intrathecal humoral immune response to recombinant virus protein 1. Nephrol Dial Transplant (1999) 0.92
Interleukin 16 expression in relation to disease activity in rheumatoid arthritis. J Rheumatol (2001) 0.92
Renal fibroblast culture. Exp Nephrol (1999) 0.92
Epac-1 activator 8-O-cAMP augments renoprotective effects of syngeneic [corrected] murine EPCs in acute ischemic kidney injury. Am J Physiol Renal Physiol (2009) 0.91
Effects of pentoxifylline, pentifylline and gamma-interferon on proliferation, differentiation, and matrix synthesis of human renal fibroblasts. Nephrol Dial Transplant (2000) 0.91
Human renal fibroblasts derived from normal and fibrotic kidneys show differences in increase of extracellular matrix synthesis and cell proliferation upon angiotensin II exposure. Pflugers Arch (2003) 0.90
Fibroblasts of rabbit kidney in culture. I. Characterization and identification of cell-specific markers. Am J Physiol (1991) 0.89
Epithelial-mesenchymal transformation of renal tubular epithelial cells in vitro and in vivo. Nephrol Dial Transplant (2000) 0.89
Expression cloning and characterization of a novel sodium-dicarboxylate cotransporter from winter flounder kidney. J Biol Chem (1999) 0.88
Cystatin C--a marker for assessment of the glomerular filtration rate in patients with cisplatin chemotherapy. Kidney Blood Press Res (2006) 0.88
Potential role of fractalkine receptor expression in human renal fibrogenesis. Kidney Int (2007) 0.88
Characterization of a cis-acting regulatory element which silences expression of the class II-A beta gene in epithelium. J Exp Med (1994) 0.87
Cadherins and integrins in renal cell carcinoma: an immunohistochemical study. Tumori (2001) 0.87
Abnormal growth and clonal proliferation of fibroblasts derived from kidneys with interstitial fibrosis. Proc Soc Exp Biol Med (1990) 0.87
Specificity of circulating and tissue-bound autoantibodies in Goodpasture syndrome. Proc Assoc Am Physicians (1996) 0.87
The hormone melatonin stimulates renoprotective effects of "early outgrowth" endothelial progenitor cells in acute ischemic kidney injury. Am J Physiol Renal Physiol (2012) 0.87
Renin in acute myeloid leukaemia blasts. Br J Haematol (1998) 0.86
Fibroblasts of rabbit kidney in culture. II. Paracrine stimulation of papillary fibroblasts by PDGF. Am J Physiol (1991) 0.86
Protease inhibitors in spontaneous cervical artery dissections. Stroke (2004) 0.86
Endothelial progenitor cells in acute ischemic kidney injury: strategies for increasing the cells' renoprotective competence. Int J Nephrol (2011) 0.86
Pseudohypercreatininemia due to positive interference in enzymatic creatinine measurements caused by monoclonal IgM in patients with Waldenström's macroglobulinemia. Nephron (2000) 0.86
Human renal tubular cells as a cytokine source: PDGF-B, GM-CSF and IL-6 mRNA expression in vitro. Exp Nephrol (1994) 0.86
Association of glomerular and interstitial mononuclear leukocytes with different forms of glomerulonephritis. Nephrol Dial Transplant (1990) 0.86
Reduction of hepatitis C virus load by H.E.L.P.-LDL apheresis. Eur J Clin Invest (2001) 0.85
Transformation of rat inner medullary fibroblasts to myofibroblasts in vitro. Kidney Int (1997) 0.85
Schimmelpenning-Feuerstein-Mims syndrome with hypophosphatemic rickets. Dermatology (2003) 0.85
Interstitial pathomechanisms underlying progressive tubulointerstitial damage. Kidney Blood Press Res (1999) 0.85
Inflammation and microvasculopathy in renal ischemia reperfusion injury. J Transplant (2012) 0.85
Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis. Scand J Rheumatol (2009) 0.85
On the progression of chronic renal disease. Nephron (1995) 0.84
The pathogenesis of chronic renal failure. Pathol Res Pract (1989) 0.84
Trastuzumab therapy vs tetracycline controlled ERBB2 downregulation: influence on tumour development in an ERBB2-dependent mouse tumour model. Br J Cancer (2008) 0.84
Characterisation of renal antigens on distinct parts of the human nephron by monoclonal antibodies. Klin Wochenschr (1983) 0.84
[Interdisciplinary AWMF guideline for the treatment of primary antibody deficiencies]. Klin Padiatr (2012) 0.84
Immunomorphological characteristics of renal cell carcinoma. Histol Histopathol (1995) 0.83
Successful treatment of a mycophenolate mofetil-refractory proliferative lupus nephritis with Belimumab in a 19-year-old woman. Lupus (2013) 0.82
Molecular evidence of organic ion transporters in the rat adrenal cortex with adrenocorticotropin-regulated zonal expression. Endocrinology (2003) 0.82
Haemolytic uraemic syndrome (HUS) during treatment with cyclosporin A after renal transplantation--is tacrolimus the answer? Nephrol Dial Transplant (1998) 0.82
Abnormal growth and clonal proliferation of fibroblasts in an animal model of unilateral ureteral obstruction. Nephron (1999) 0.81
Demonstration of a probenecid-inhibitable anion exchanger involved in the release of cortisol and cAMP and in the uptake of p-aminohippurate in bovine adrenocortical cells. Cell Physiol Biochem (1999) 0.81
Effect of continuous hemodiafiltration on IL-6, TNF-alpha, C3a, and TCC in patients with SIRS/septic shock using two different membranes. Contrib Nephrol (1995) 0.81
Bioimpedance analysis and intradialytic hypotension in intermittent hemodialysis. Clin Nephrol (2006) 0.81
Benign prostatic hyperplasia (BPH) requiring transurethral resection in freshly transplanted renal allograft recipients. Clin Nephrol (2004) 0.81
Up-regulation of the human serum and glucocorticoid-dependent kinase 1 in glomerulonephritis. Kidney Blood Press Res (2002) 0.81
Effective treatment of hepatitis C-associated immune-complex nephritis with cryoprecipitate apheresis and antiviral therapy. Clin Nephrol (2007) 0.80
Microvasculopathy in ischemic acute kidney injury: consequences and therapeutic implications. Panminerva Med (2012) 0.80
Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium. Scand J Rheumatol (2008) 0.80
First steps toward the establishment of a German low-density lipoprotein-apheresis registry: recommendations for the indication and for quality management. Ther Apher (2002) 0.79
Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data. Neoplasma (1999) 0.79
Rapid improvement of SLE-specific cutaneous lesions by C1q immunoadsorption. Ann Rheum Dis (2001) 0.79
Soluble CD-4 and CD-8 as markers of immunological activation in renal transplant recipients. Nephrol Dial Transplant (2000) 0.79
Oxidative stress during dialysis: effect on free radical scavenging enzyme (FRSE) activities and glutathione (GSH) concentration in granulocytes. Nephrol Dial Transplant (1998) 0.79
Infliximab as therapeutic option in steroid-refractory ulcerative colitis after kidney transplantation: case report. Transplant Proc (2010) 0.79
Chronic renal transplantation: a model for the hyperhomocysteinemia of renal insufficiency. Atherosclerosis (2001) 0.78
Membranous nephropathy after bone marrow transplantation in ciclosporin treatment. Nephron (1989) 0.78
Treatment of relapsing thrombotic thrombocytopenic purpura with cyclophosphamide pulse therapy. Nephrol Dial Transplant (1998) 0.78
Expression of HLA-DQ, -DR, and -DP antigens in normal kidney and glomerulonephritis. Kidney Int (1989) 0.78